
Please try another search
Investing.com -- Novartis (SIX:NOVN) on Monday said that its cancer drug Pluvicto showed positive results in a late-stage trial for patients with an earlier form of advanced prostate cancer. The...
Investing.com - U.S. President Donald Trump on Monday signed an executive order aimed at boosting domestic pharmaceutical production, and warned that he will soon impose import tariffs on the...
Investing.com -- Novartis (SIX:NOVN) hiked its full-year earnings outlook on Tuesday, driven by strong demand for key therapies including Leqvio, Kisqali, and Kesimpta in the first quarter. The...
Investing.com -- The investment entity of the Sandoz (SIX:SDZ) family, Emasan AG, has sold a substantial portion of its stake in Swiss pharmaceutical giant Novartis (SIX:NOVN), netting 2.6...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review